Showing results (321-330 of 349) with videos related to
Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T CellsJay Friedman, Ellen C Moore, Paul Zolkind, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomasJohn L Marshall, James L Gulley, Philip M Arlen, et al.Elife|July 8, 2020
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cellsYvette Robbins, Sarah Greene, Jay Friedman, et al.Journal of Translational Medicine|May 31, 2024
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responsesRiley M Larkin, Diana C Lopez, Yvette L Robbins, et al.Journal of Virology|September 6, 2005
Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virusJames L Murray, Manos Mavrakis, Natalie J McDonald, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancerJames L Gulley, Philip M Arlen, Anne Bastian, et al.Oncotarget|November 19, 2016
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 alleleCaroline Jochems, James W Hodge, Massimo Fantini, et al.Alcoholism, Clinical and Experimental Research|June 5, 2002
The corticotropin-releasing factor/urocortin system and alcoholAndrey E Ryabinin, Ryan K Bachtell, Stephen C Heinrichs, et al.Psychopharmacology|July 18, 2025
Transmembrane AMPA receptor regulatory protein TARP ɣ-8 is a target of ethanol that regulates self-administration and relapse in miceSara Faccidomo, Jessica L Hoffman, Julie Lee, et al.Journal for Immunotherapy of Cancer|July 1, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regressionGinette Santiago-Sanchez, Francesca Rosato, Kellsye P Fabian, et al.Pageof 35